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Abstract.  The members of the multigene family of in- 
termediate filament (IF) proteins are expressed in vari- 
ous combinations and amounts that are specific for a 
given pathway or state of differentiation.  Previous ex- 
periments in which the cell type-specific IF cytoskele- 
ton was altered by introducing  foreign IF proteins into 
cultured cells or certain tissues of transgenic animals 
have shown a remarkable tolerance,  without detectable 
interference with cell functions.  To examine the im- 
portance of the cell type-specific cytokeratin (CK) IF 
pattern,  we have studied the ectopic expression of CK 
genes in different epithelia of transgenic  mice.  Here 
we report changes observed in the 13 cells of pan- 
creatic islets expressing the genes for human epider- 
mal CKs  1 and/or  10 brought under control of the rat 
insulin promoter.  Both genes were efficiently ex- 
pressed, resulting  in the appearance of numerous and 
massive bundles of aggregated IFs,  resembling those of 
epidermal keratinocytes. While the synthesis of epider- 
mal CK 10 was readily accommodated and compatible 
with cell function,  mice expressing CK 1 in their/~ 
cells, alone or in combination with CK 10, developed 
a  special form of diabetes characterized by a drastic 
reduction of insulin-secretory vesicles and of insulin- 
and CK 1-producing cells.  In many CK 1-producing 
cells, accumulations of fibrous or granular  material 
containing  CK  1 were also seen in the nucleus.  This 
demonstration of functional importance of the specific 
CK-complement in an epithelial cell indicates a contri- 
bution of cell type-specific factors to cytoplasmic IF 
compartmentalization  and that the specific CK comple- 
ment can be crucial for functions and longevity of a 
given kind of epithelium. 
F the three major cytoskeletal filament  systems,  the 
actin  microfilaments,  the  microtubules,  and  the 
intermediate-sized  filaments  (IFs), t  the  latter  are 
still enigmatic  as, up to date,  no distinct  cellular  functions 
can be ascribed to them. While microfilaments and microtu- 
bules  are  ubiquitous  elements  also  involved  in  general 
("housekeeping")  cell functions,  IFs and IF proteins are not 
imperative components and obviously do not serve the same 
functions in different cells.  (a) The more than 40 members 
of this large multigene family are expressed in different com- 
binations  in  relation  to  cell  differentiation  pathways.  (b) 
Most puzzling,  several cultured cell lines and tumors are to- 
tally devoid of IF proteins (e.g., 33, 40, 54, 78). (c) The type 
of IF protein present in the same cell type can grossly differ 
from one species to another (for review, see 30).  (d) Intra- 
cellular immunoprecipitation  of IFs by injected antibodies 
does not result in detectable functional  damage  (e.g.,  32, 
46, 47, 55). 
1.  Abbr~,viations  used  in  this paper:  CK,  cytokeratin;  IDDM,  insulin- 
dependent diabetes mr  IF, intermcxiiate-sized  filaments; RIP, rat insu- 
lin promoter. 
Elucidation  of the possible functions  of IFs has been at- 
tempted in various laboratories along three major lines of ex- 
perimental research as follows. The most rigorous approach, 
i.e., the targeted elimination of a specific IF protein gene by 
homologous recombination techniques,  has  recently been 
taken in several laboratories. The only result reported so far 
has been negative (7): Mouse embryo cells in which the gene 
encoding the only type II cytokeratin (CK) expressed, i.e., 
CK  8,  has  been disrupted,  can  no  longer  form  IFs,  but 
nevertheless  differentiate  to  a  well  organized  polar  epi- 
thelium. 
In a second line of research, cells or animals  have been 
transfected  with genes encoding an experimentally mutated 
IF protein, resulting  in structural  alterations  of the endoge- 
nous IF system. Using this approach,  it has been shown that 
expression of a gene encoding a CK defective in the central 
"rod"  domain  (for  reviews  see 2,  75)  leads  to  dramatic 
changes in the IF system, notably aggregate  formation,  the 
formation  of which correlates,  in transgenic  mice, with se- 
vere defects of intercellular  coherence (3, 4,  15, 57, 77, 78, 
82). The similarity of these effects in transgenic  mice carry- 
ing and expressing a defective CK gene to the inheritable  hu- 
￿9  The Rockefeller University  Press, 0021-9525/93/02/743/13  $2.00 
The Journal of Cell Biology, Volume 120, Number 3, February 1993 743-755  743 man blistering disease Epidermolysis bullosa simplex (EBS) 
has  recently led to the discovery that human EBS  is  as- 
sociated with certain mutations in the rod portion of CK 14 
or CK 5 (12, 16; see also 43). When similarly defective des- 
min molecules were introduced into cultured fibroblasts or 
myoblasts, aggregate formation and extensive disorganiza- 
tion of the desmin/vimentin IF system was also observed 
but this did not affect cell function and sarcomeric differenti- 
ation (73). 
In a third kind of experimentation, the cell's IF system has 
been disturbed by the forcefully induced "ectopic" or dys- 
regulated expression of one or several IF protein genes, ei- 
ther by microinjection of the IF protein (79) or the corre- 
sponding mRNA (28,  41,  49),  or by transfecting cultured 
cells or mice with IF protein genes brought under control of 
promoters directing their expression to different kinds of 
cells, including cases of ectopic expression and overexpres- 
sion (6, 8, 13, 18, 19, 34, 51, 53, 57, 64, 66). These experi- 
ments have shown that foreign or overexpressed IF proteins 
are well accommodated in the recipient cultured cells as well 
as in the transgenic animals, without noticeable effects on 
function or phenotype, the only exception reported being 
cataract formation in eye lenses filled with overexpressed IFs 
of various kinds (vimentin, desmin, neurofilament protein; 
13,  19, 64). 
All these results  have led to the general view that,  in 
many different kinds of cells and tissues, neither the type 
nor the amount of IFs really matters for cell function and 
morphology. Even when ectopically synthesized epidermal 
CKs  were  expressed  in  mammary gland-derived cells in 
great excess over the endogenous CKs, the resulting perma- 
nent cell lines were perfectly viable and did not reveal major 
shape changes (8). 
To examine whether the cell's IF composition might be im- 
portant for certain special functions and/or differentiation 
processes we targeted, in transgenic mice, the ectopic ex- 
pression of certain IF protein genes to some cell types that 
are known for distinct, very sensitively balanced functions. 
Here we report the specific results obtained after disturbing 
the cytoskeleton of the B cells of pancreatic islets by the ex- 
pression of CKs  1 and  10,  i.e.,  hallmarks of suprabasal 
differentiation of epidermis (e.g., 23, 24, 31, 71). We show 
that these cells do not tolerate a specific "wrong" CK, i.e., 
CK 1, and that both their insulin-secretory function and their 
lifetime is drastically reduced, resulting in diabetes, whereas 
another foreign CK, i.e., CK 10, is well accepted, even when 
present in large amounts. 
Materials and Methods 
Genes and Constructs 
A genomic ),-clone (M(J-I1) for the human CK 1 gene was isolated from a 
genomic library using oligonucleotide  probes corresponding to various 
parts of the sequence published by Johnson et ai.  (44).  The clone was 
characterized and identified by restriction enzyme mapping and by partial 
sequence  analysis.  The  genomic  clone  for  the  human  CK  10  gene 
(hKH105) has been previously  described (69). The construct RIP-Tag car- 
tying the SV-40 T-antigen under the control of the rat insulin gene promoter 
(see reference 36) was a kind gift of Dr. D. Hanahan (University of Califor- 
nia, San Francisco,  CA), the construct pSV2fl-globin is a derivative of pSV2 
(52). 
The genes for CKs 1 and 10 were brought either under the control of the 
rat insulin gene promoter (RIP-H1 and RIP-H10) or the SV-40 promoter 
(SV-H1 and SV-H10) as summarized in Fig.  1. 
Cell Cultures and Transfections 
3T3-L1 preadipocytes  (ATCC CL 173; 29) and HeLa cells (ATCC CCL 2) 
were cultured in DME supplemented with 10% FCS.  Transfections  were 
performed using the calciumphosphate-DNA coprecipitation  technique (see 
reference  8). 
Generation of Transgenic Mice 
Transgenic  mice were generated by pronuclear injection of an eqnimolar 
mixture  of the  10-kb  EcoRi  fragment of RIP-H1 and  of the  5.18-kb 
XhoI-NotI fragment of RIP-H10. In total, 21 offspring were born and subse- 
quently analyzed for the presence of the transgene by Southern blotting. 
Two male animals were detected carrying the RIP-H10 construct alone (Tgl- 
RIP-H10 and Tg2-RIP-H10). In addition, two females were found which car- 
tied  either the RIP-H1 construct alone (Tg-RIP-H1) or both constructs 
(Tg-TIP-H1/10). All four founder animals transmitted the transgenes to 
offspring, and breeding of line Tg-RIP-H1/10 confirmed that the constructs 
RIP-H1 and RIP-H10 were integrated on the same chromosome, most likely 
at the same integration site.  Since RIP-HI  transgene-positive  animals be- 
come hyperglycemic  and sick early in life (6-10 wk of age) only positive 
maies were used for further breeding immediately upon sexual maturation. 
All experhnents with mice were performed on F1 and F2 mice of a cross 
between C57BL/6 and SIL mice. 
During the study, a total of 69 transgenic mice of line Tg-RIP-H1, 47 of 
line Tg-RIP-H10, and 40 of line Tg-RIP-H1/10 were examined. 
Antibodies 
Monoclonai CK1 antibody EAB-904 was from Enzo Biocbem (Neckarge- 
miind, FRG). RKSE60, a monoclonal murine antibody specifically reacting 
with CKs 10 and 11, and guinea pig antibodies to insulin were obtained from 
Bio-Science  Products  (Emmenbriicke,  Switzerland).  A monoclonal anti- 
body reacting with CKs 1, 10, and 11 (KK8.60, from Bio-Makor,  Rehovot, 
Israel) has been described in detail (42). For the visualization of glucagun 
we used a rabbit antiserum (Bio Trend, Ktln, FRG) or monoclonal murine 
antibody 23.6B4  (35).  Synaptophysin  antibody SY38 (80)  served as  a 
general neuroendocrine  marker. Murine CKs ortholog to CKs 8 and 18 were 
detected by specific guinea pig antibodies (available from Progen, Heidel- 
berg, FRG) or with mAbs TROMA 1 and TROMA 2 (11). A broad range 
monoclonal CK antibody,  lu-5,  was obtained from Hoffmarm-La  Roche 
Diagnostica  (Basel,  Switzerland).  For identification  of lymphoeytes  and 
macrophages  we applied antibodies recognizing  Thy-1, CD2,  CD45,  and 
a,~TCR (all from Dianova, Hamburg, FRG). FILE- and Texas red-labeled 
secondary  antibodies were also from Dianova. 
Measurement of  Blood Glucose 
Blood  obtained from the tail was allowed to clot  for 1 h. After centrifugation 
the serum was collected and glucose levels were determined using a Beck- 
man glucose analysator (the kind help of Dr. M. Zorn, Krehl Clinic for In- 
ternal Medicine,  University of Heidelberg,  is acknowledged). 
Gel Electrophoresis and Protein Identification 
Cytoskeletal  preparations, two-dimensional  gel electrophoresis (2-D GE) 
and immunoblotting tests were performed essentially as described (1). Im- 
munoblot reactions of nitrocellulose-bound  polypeptides with monoclonal 
mufine antibodies were visualized by secondary reaction with t2SI-labeled 
goat antibodies to mouse IgGs (Amersham-Buchler,  Brannschweig,  FRG), 
followed by autoradiography. 
Light Microscopy and Immunolocalization 
Tissue samples were routinely fixed and processed for paraffin-embedding 
and hematoxylin-eosin (H&E) staining (the cooperation of Dr. E Amelung, 
this Center, is gratefully acknowledged).  For immunolocalizatiun,  cultured 
cells were fixed 40 h after transfection with cold (-20~  methanol/acetone 
for 5 rain and frozen sections (5 #m) of tissue samples with acetone for 10 
min. Single- and double-label immunofluorescence  microscopy  were per- 
formed as described (28). 
Electron and Immunoelectron Microscopy 
Tissue  samples  were  fixed  in  2.5% glutaraldehyde  in  50  mM  sodium  caco- 
dylate  buffer,  pH 7.4,  containing  50 mM  KCI and 2.5 mM  MgCI2 for  20 
min, washed  in  buffer,  "postfixed"  for  2 h with  2% osmium tetroxide  in  25 
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acetate (in water).  Alternatively,  samples were fixed simultaneously with 
2.5% glutaraldehyde  (same buffer) for 20 min plus 1% osmium tetroxide. 
After a  second fixation  with 2%  OsO4 solution in 25  mM  cacodylate 
buffer, samples were block-stained overnight in 0.5 % uranyl acetate (in wa- 
ter). All further procedures were as described (28). 
Cryosections (5  ~tm) mounted on coverslips  were fixed  as described 
above, incubated with CK antibodies for 30 min in a wet-chamber,  washed 
with PBS three times for 5 min each, and incubated overnight with "v5 ~m 
colloidal gold particles coated by conjugated IgG (Amersham-Buchler). Af- 
ter three washes with PBS, samples were fixed with 2.5% glutaraldehyde 
for 15 rain, washed,  postfixed with 2% OsO4 for 30 min, dehydrated,  and 
fiat-embedded  in Epon 812 (see reference  28). 
Alternatively, the bound antibodies were reacted with ,'~l-nm-diam gold 
particles coated with anti-mouse lgG (Bio Trend, Aurion Gold Reagents) 
overnight, washed three times with PBS, fixed first with glutaraldehyde,  and 
then with OsO4 (see above),  and finally washed with distilled water.  For 
"silver enhancement; sections were then exposed  for 3 min to a mixture 
of one part "Developer" and one part "Enhancer" (Bio Trend, Aurion) mixed 
immediately before use. 
When CK antibody lu-5  was used,  sections were first fixed with 2 % 
freshly prepared formaldehyde  (in PBS)  for 20 min, then perrneabilized 
with 0.1% saponin (in PBS) for 10 rain, and incubated as described above. 
Results 
Gene Constructs and Their Expression in 
Cultured Cells 
For studies of the synthesis and assembly of human epider- 
mal differentiation CKs 1 and 10 in ceils in which they nor- 
mally are absent, we have brought the human genes encoding 
thee proteins (see references 44,  69) under the control of 
different promoters. Here we specifically describe the results 
obtained with the rat insulin promoter (RIP; see reference 
36),  for cell type-specific expression in pancreatic/~ cells, 
and with the SV-40 promoter, for permissive expression in 
several different cell types. The constructs used are schemat- 
ically shown in Fig.  1, a  and b. 
Transcription of the transfected genes, translation of the 
encoded mRNA, and the structural assembly of the resulting 
protein(s) were examined by transient transfections of cul- 
tured cells of several lines, and in some examples also in sta- 
bly transfected cells selected for introduced neomycin resis- 
tance (see reference 8).  Using antibodies which react only 
with human CK 1 or CK 10 or both, the structures formed 
in  the  transfected  cells  were  routinely  studied  by  im- 
munofluorescence microscopy. 
These epidermal CKs encoded by the constructs shown in 
Fig.  1 were able to integrate into a  pre-existing CK fibril 
meshwork or to form CK fibrils de novo, as demonstrated 
by transient transfections of different cell culture lines. For 
example, upon transfection of diverse epithelial cell lines, in- 
cluding HeLa cells (Fig. 2 a), with one or both of the SV-40 
promoter-driven constructs (Fig. 1 b), we noticed the forma- 
tion of meshworks of CK 1- or CK 10-positive cytoplasmic 
fibrils.  In  double-label  immunofluorescence  microscopy, 
far-reaching  colocalization of these  foreign  CKs with  the 
endogenous CKs 7, 8, 17, and 18 (60) was seen, confirming 
the  co-assembly  of the  forcefully  synthesized  epidermal 
CKs and the endogenous CKs into a common IF system, as 
previously shown for various other CKs and cell lines  (8, 
28,  34, 51). 
After double transfection of nonepithelial cells devoid of 
any endogenous CK IFs with both human CK genes, the de 
novo formation of CK 1- and CK 10-positive fibrillar struc- 
tures or aggregates was observed (Fig. 2 c, murine 3T3-L1 
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Figure 1. Construction of plasmids containing the genes for human 
CKs 1 (a) and 10 (b) under the control of either the SV-40 promoter 
or the RIP. Exons are represented  by open rectangles,  promoter 
fragments by hatched rectangles, introns and flanking sequences as 
lines. C, ClaI; E, EcoRI; H, HindI~: K, KpnI; N, NIaIV; No, NotI; 
P, PstI; Pv, PvulI; S, SalI; SII, SaclI; Sa, SacI; Sp, SphI; and X, 
XhoI. (a) A genomic h-clone  (AKH/) containing the whole CK 1 
gene and several kilobases of flanking regions were used. A 10-kb 
fragment generated by partial SalI digest and ranging from the sec- 
ond codon to '~3 kb downstream from the polyadenylation site, was 
cloned in the correct orientation  into the SalI site of a derivative 
of pUC8 in which the PstI site has been destroyed by treatment with 
Klenow DNA polymerase and a ClaI site has been introduced with 
an octameric ClaI linker, thereby restoring the ATG start codon in 
the correct frame. In the resulting plasmid, H1-MC, the codon for 
serine (AGT) following the start codon was changed to a glycine 
codon (GGT; not shown). The gene was then coupled either to the 
SV-40 promoter by cloning the 10-kb HindllI/EcoRi insert of H1- 
MC into the pSV2/3-globin construct opened with HindlII/EcoRi 
to yield SV-H1, or to RIP by inserting the 750-bp BamHI/HindlII 
fragment to RIP-Tag  into the HindlR site of H1-MC, using HindIII 
linkers, to yield RIP-H1. (b) The 180-bp NlalV/SacI fragment of 
)~KHI@, a genomic clone encoding human CK 10, was inserted 
into pUC 18 cleaved by SphI/SacI double digestion. Then the 5-kb 
SacI fragment was added in the correct orientation to yield pill0. 
The 5.18-kb insert of pill0 was excised by HindlII/EcoRI partial 
digestion and cloned into Bluescript opened by HindlII/EcoRI  dou- 
ble digestion. The resulting plasmid H10-MC contains the CK 10 
gene from the ATG site to ',,0.5 kb downstream of the polyadenyla- 
tion site (not shown). The gene was then coupled either to the SV-40 
promoter by cloning the 5.18-kb HindlR/EcoRI partial fragment of 
H10-MC into pSV2/3-globin opened with HindIII/EcoRi to yield 
SV-HI0, or to RIP as described  in (a) to yield RIP-H10. 
preadipocytes; for vimentin IFs in these cells see reference 
29). This confirms previous observations made after double 
transfections of gene constructs encoding other type I and II 
CKs (e.g., 6,  8,  34,  50,  57). 
In some experiments showing the fibril-forming compe- 
tence of CKs 1 and 10, we occasionally also noticed cells in 
which  CK-positive material was concentrated  in "dots" or 
"whiskers" around the nuclear surface or even in the nuclear 
interior (Fig.  2, b  and d). 
Transgenic Mice and Ectopic Cytokeratins 
Both acinar and islet cells of the mammalian pancreas con- 
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CKs 1 and 10 in HeLa cells (a and b) and murine preadipoyctes of 
line 3T3-LI (c and d) after transient transfection with construct SV- 
H1 alone (HeLa ceils, a and b) or with both SV-H1 and SV-H10 
(preadipocytes, c and d).  mAb Kx8.60 specifically recognizing 
both human CKs 1 and 10 but not reactive with endogenous HeLa 
CKs has been used. Note that in the cytoplasm of both cell types 
the newly synthesized epidermal CK1 can form filamentous struc- 
tures, either with an endogenous type I CK (a) or with the cotrans- 
fected epidermal pair-partner, human CK 10 (c). In a number of 
such transfected ceils, we have also observed intranuclear or jux- 
tanuclear (b and d) CK dot- or rod-like structures. N, nuclei of cells 
not showing CK expression. Bars, 25/xm. 
tain typical, albeit small desmosomes and bundles of IFs pri- 
marily composed ofCK 8 and CK 18 and enriched in the cell 
periphery, mostly at desmosomes.  The frequency of both 
structures, however, is much lower in islet cells (e.g., 45, 61, 
62, 81). The extremely low content of CKs (and thus of IFs) 
in all types of islet cells characteristically results in a very 
weak,  sometimes even negative-appearing CK immunolo- 
calization of islets (data not shown). Reactions with antibod- 
ies specific for human epidermal CKs 1 and 10 were consis- 
tently negative on all pancreatic cells. 
Transgenic mice containing one or both  of the  human 
genes for epidermal CKs 1 and 10 under RIP control devel- 
oped normally until ,x,2 wk after birth, without changes de- 
tectable in islets  stained with H&E, but their further fate 
differed dramatically: all mice expressing the transgene for 
CK  1  in  the  /3  cells  of their pancreatic  islets  developed 
insulin-dependent diabetes mellitus (IDDM), whereas those 
expressing only the CK  10 gene appeared normal. 
Mice of line Tg-RIP-H10 containing only the human CK 
10 gene (two different founder lines, Tgl and Tg2, and a total 
of 47 animals) showed synthesis of human epidermal CK 10 
in/3 cells of  pancreatic islets which appeared in abundant and 
relatively large fibrillar structures (Figs. 3, a-a", and 4, a and 
a').  In double-label immunofluorescence microscopy, most 
of  the CK 10-positive fibrils were also positive for the endog- 
enous CKs 8 and  18 (Fig. 4, a  and a).  The occurrence of 
both ectopic human CK 10 and endogenous murine CKs 8 
and 18 in the massive fibrils, which are not seen in islets of 
normal mice, was also evident from step-sections immuno- 
stained with CK antibodies of the Troma series (not shown). 
EM showed that this additional CK 10 was contained in mas- 
sive bundles of  normal-looking but densely fasciated IFs (see 
below). The CK 10-positive cells showed normal intensity 
of immunostaining for insulin (Fig.  3 a') and general neu- 
roendocrine markers such as synaptophysin (not shown; see 
references 68,  81).  These mice were healthy and their life 
span was normal. Only very occasionally, cells with sparse 
nuclear CK  10-immunofluorescence were also seen. 
By contrast, mice that contained and expressed the human 
CK 1 gene, either alone (Tg-RIP-H1; total number of animals 
studied: 40), or together with that for CK 10 (Tg-RIP-H1/10; 
total number: 69), invariably developed, mostly at 2-10 wk 
of age,  symptoms characteristic of IDDM with polydipsia 
and polyuria, typical diabetic behavior, and serum glucose 
concentrations  of  a  mean  value  of  760  mg/dl  (range: 
634-990  mg/dl;  nontransgenic  controls  and  Tg-RIP-H10 
mice presented mean values of 181 mg/dl). IDDM was also 
seen in the F1 offspring of  matings between Tg-RIP-H1 males 
and  Tg-RIP-H10 females which carded the RIP-H1  trans- 
gene, either alone or together with the maternally inherited 
RIP-H10  transgene.  The  disease  usually  progressed  only 
moderately in both sexes but, in the absence of dietary and 
therapeutic interventions, invariably led to death within sev- 
eral months. 
Histological examination of the pancreatic islets  of CK 
1-positive mice showed, with increasing time, some disorder 
of tissue architecture with an increased frequency of irregu- 
larly contoured, shrunken islets, and sparse, scattered/3-cells 
(see Fig. 3, b-d"). On immunofluorescence microscopy with 
antibodies to neuroendocrine marker proteins and to CKs, 
extensive alterations of the IF cytoskeleton were noticed in 
these mice. Most notable was the appearance of small dot- 
like CK 1-positive structures, usually both in the nucleus and 
in  the cytoplasm,  which  were also  seen in  Tg-RIP-H1/10 
double-transgenic mice (Fig.  3, b-b"). 
Double-label  immunofluorescence microscopy  revealed 
that most/3-cells could routinely be identified by their posi- 
tive reactions for synaptophysin and insulin as well as for hu- 
man CK 1 and, in Tg-RIP-H1/10 mice, CK 10 (Fig. 3, b-d"). 
The positive CK 1 or CK 10 reactions often appeared as dots, 
rods,  or whiskers,  some of which could be related to the 
cytoplasm, whereas others were clearly located at or within 
Figure 3.  Expression of human epidermal CKs in pancreatic islet cells of transgenic mice and progressive changes of islet organization 
and/or the frequency of/3 cells. Phase contrast (a-d) and double label immunofluorescence (a'--d') microscopy of frozen sections through 
pancreata of transgenic mice of lines Tgl-RIP-H10  at the age of 15 mos (a, a' and a~), and Tgl-RIP-H1 of 2 (b, b' and b") and 10 (c, c', 
and c") weeks, and in double-transgenic mice of line TgI-RIP-H1/H10  at postnatal week 10 (d, d', and d'), immunostained with guinea 
pig antibodies to insulin (a', b', c', and d') and mAb Kx8.60 specific for CKs 1 and 10 (a ~, b',  c", and d"). The contours of the islets 
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sive fibrous strucaures containing human CK 10 are seen in these cells (a"). Islets of mice expressing the transgenic CK 1 (b-d) show 
remarkable changes: in the islet shown in (b'-b") many of the/3 cells (b') produce human epidermal CK in small whisker- or dot-like 
structures, some of them apparently in nuclei (b"). With increasing age (c-d") the number of cells positive for insulin (c' and d') and 
CK (c" and d ") is drastically reduced (the insert in c ~  shows the intranuclear location of punctate CK deposits in an insulin-positive  B-cell; 
see c'). Bars, 50/zm. 
Blessing ct al. Ectopic Cytokeratina in Islet Cells  747 Figure  4.  Colocalization  of 
transgenic  human  CKs  and 
complementary  endogenous 
murine CKs 8 and 18 by dou- 
ble-label immunofluorescence 
microscopy of sections  through 
pancreatic islets of transgenic 
female  mice  (3-mos-old)  of 
lines ~I-RIP-H10 (a and a') 
and  TgloRIP-H1 (b  and  b'), 
using  guinea  pig  antibodies 
for CKs 8 and 18 (a and b) in 
combination  with  CK  10- 
detecting monoclonal murine 
antibody  KxS~60 (a') or CK 
1-specific antibody EAB-904 
(b'). Note the intense reaction 
ofCKs 8 and 18 on acinar (A) 
and ductal (D) structures com- 
pared with a less intense but 
fibrous reaction on the cells of 
the islets (a and b).  In con- 
trast,  the reaction for the ec- 
topic epidermal-type CKs 10 
(a') and 1 (b') is exclusive for 
0-cells  of islets where it ap- 
pears predominantly  fibrillar in 
(a') or predominantly granu- 
lar in (b').  In the latter situ- 
ation,  a  number  of the  CK 
1-positive "dots" are  located 
within nuclei. In normal con- 
trol  mice,  these  islet  cells 
show only very sparse, small 
and faint structures immuno- 
stained  for  CKs  8  and  18. 
Bars, 25 ~m. 
cell nuclei (Figs. 3, b' and b ~, and 4, b and b'). Double-label 
immunofluorescence microscopy with additional antibodies 
reactive with routine CK 8 or CK 18 showed coincident im- 
munostaining in many but not all CK 1-positive structures, 
indicating that most of them also contained endogenous CKs 
and that endogenous and ectopic CKs mix (Fig. 4, b and b'). 
With progressing IDDM, the number of insulin-positive 
cells decreased drastically and the distribution of  the residual 
/3 cells was also altered. Some of the few residual and scat- 
tered insulin-containing cells also  showed punctate CK  1 
and/or CK 10 immunofluorescence, which was often addi- 
tionally, or even exclusively, in the nucleus (Fig. 3, c-c"). 
Essentially similar situations were found in pancreatic islets 
of  Tg-RIP-H1 and Tg-RIP-H1/10 mice (e.g., Figs. 3, d-d n, and 
4  b'). Glucagon-positive c~ cells were still present at near- 
normal frequency  and were generally negative for CK 1 and/ 
or CK 10 (not shown). 
The onset and the rate of  development of  IDDM symptoms 
in mice carrying the human CK 1 gene under RIP control 
varied considerably from mouse to mouse, even in the same 
litter. While some Tg-RIP-H1/10 mice showed the first symp- 
toms at postnatal weeks 2-4, others appeared symptom-free 
until weeks 8-10. 
There was also remarkable variability between islets of the 
same pancreas and between/3 cells of  the same islet. Normal- 
Figure  5.  Autoradiofluorograph  showing gel  electrophoretic 
identification of  transgenic gene product by immunoblot analysis of 
cytoskeletal proteins of pancreata from 10 transgenic mice of line 
Tgl-RIP-H1 (a) and four transgenic mice of line Tgl-RIP-HI]10  (b) 
after separation by 2-D GE (horizontal  arrow,  direction of non- 
equilibrium pH gradient electrophoresis; downward arrow, SDS- 
PAGE), using antibody EAB-904 specific for CK 1 (isoelectric 
variants are denoted by brackets).  Positions of reference proteins 
used for coelectrophoresis have been determined by Poinceau S 
staining. B, BSA; P, phosphoglycerokinase. 
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graphs  showing the  appear- 
ance of massive CK filament 
bundles in routine pancreatic 
/3  cells  expressing  human 
epidermal  CK  1  and/or  10 
alone or in combination. Pan- 
creata  of mice  of lines  Tgl- 
RIP-H1/10 (a and b; 8 wk old 
mice),  Tgl-RIP-H10 (c, d;  8 
wk)  and  Tgl-RIP-H1 (e, f; 
5 wk) were fixed, embedded, 
ultrathin  sectioned,  and  ob- 
served. Many/3 cells of islets 
containing  numerous  dense- 
core vesicles  (some  are  de- 
noted by asterisks in b-d) ac- 
cumulate  human  epidermal 
CK  1  and/or  10  assembled 
into  numerous  and  densely 
stained bundles (brackets in b 
and c) of tightly packed fila- 
ments  (a,  survey picture;  b, 
partial  magnification) in  the 
cytoplasm  (a-d)  and/or  the 
nucleoplasm (arrows in e and 
f; e, survey,  f, partial magni- 
fication).  Individual  IFs  are 
locally resolved in some cyto- 
plasmic (d) and nuclear (inset 
in e) bundles. N, nucleus; M, 
mitochondria;  lines in d de- 
note the '~22-nm periodicity. 
Bars: (a and e)  1 #m; (b, c, 
and  f) 0.5 #m; (d, and inset  in 
e) 0.2 ~m. 
sized islets with normal morphology were seen next to others 
showing extensive structural distortion with only few scat- 
tered insulin-positive cells left. Immunofluorescence  micros- 
copy using a panel of markers for macrophages (monocytes) 
and lymphocytes (see Materials and Methods) did not reveal 
any significant inflammatory infiltration which would be in- 
dicative of autoimmune insulitis (not shown). 
The expression of human CK 1 and CK 10 in murine pan- 
creatic islets was confirmed by 2-D GE of cytoskeletal pro- 
teins residual after extractions with detergent and high-salt 
buffers (see reference 60), followed by immunoblotting with 
antibodies specific for human CK  1 and/or CK  10.  Fig.  5 
presents, for example, the identification of human CK 1 in 
pancreatic tissue of Tg-RIP-H1  (Fig. 5 a) and Tg-RIP-H1/10 
(Fig.  5 b) mice. 
Islet Pathogenesis As Seen in the Electron Microscope 
In/3 cells, the new cytoskeletal structures comprising human 
epidermal CK 1, CK 10, or both were readily recognized as 
bundles of densely fasciated IFs throughout the cytoplasm, 
although often with a marked accumulation in the vicinity of 
the nucleus  (Fig.  6,  a  and b).  These abundant  and thick 
epidermal CK-containing IF bundles, which often appeared 
in close association with the dense-core vesicles containing 
insulin  (Fig.  6,  a-d),  differed strikingly from the sparse, 
short, and loose-packed tufts of the endogenous CK 8- and 
CK 18-containing IFs characteristic of normal islet cells. 
The very dense packing of these new IF bundles contain- 
ing epidermal CKs, up to 0.25 #m in diameter and some- 
times  showing  local  ,~22-nm  cross-striation  (Fig.  6  d), 
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scopic immunolocalization of 
human epidermal CKs in pan- 
creatic islet/3 cells of trans- 
genic mice. An intensive im- 
munogold reaction  of mAbs 
EAB-904 and RKSE60, spe- 
cific for human CKs 1 and 10, 
is seen in Tg-RIP-H1/10  mice, 
with (a and c) or without (b) 
silver  enhancement  of  anti- 
body-coated  colloidal  gold 
particles,  showing the  spe- 
cific decoration of IF bundles 
with antibodies to CKs 1 and 
10.  Note  intense labeling of 
juxtanuclear  (10-30-nm-large 
silver grains in a and c, 5-nm 
gold particles in b and c; in- 
dividual IFs are resolved in b) 
as  well  as  intranuclear  (ar- 
rows  in  c  denote both  cyto- 
plasmic  and  nucleoplasmic 
structures) IF bundles. N, nu- 
cleus; C, cytoplasm; NE, nu- 
clear envelope; No, nucleolus. 
The bracket in a  indicates a 
nuclear reaction site not obvi- 
ously related to an IF bundle. 
Bars:  (a and b) 0.2  #m;  (c) 
0.5 t~m. 
strikingly  resembled the  IF  bundle  aggregates  typical of 
differentiating epidermal keratinocytes, notably in the gran- 
ular layer (e.g.,  17, 63). 
In  a  number  of islet  cells,  densely packed  and  darkly 
stained bundles of IF structures were also detected in the 
nucleoplasm (Fig. 6  e), often at high frequency, and these 
also occasionally revealed local cross-striation (Fig.  6 f). 
Nuclear bundles of filaments or other CK structures were 
only rarely detected in Tg-RIP-H10 transgenic mice but were 
very frequent in the two lines carrying CK 1. 
That these unusually thick and dense bundles of  IFs indeed 
contained the human epidermal CKs 1 and/or 10 was shown 
by immunoelectron microscopy (Fig.  7,  a-c).  Besides the 
immunogold particle decoration of these bundles, we also 
occasionally found small clusters of gold particles elsewhere 
in the nucleus (e.g., Fig. 7 a),  indicating that some of the 
foreign CK material may exist in non-IF states. 
In addition to fibrillar CK assemblies, we also noted, in 
Tg-RIP-H1  mice, accumulations of variously sized, irregu- 
larly shaped and densely stained amorphous CK material, in 
the cytoplasm and/or in the nucleus, which by immunogold 
labeling showed intense CK 1-1abel (not shown). 
During IDDM development, we noticed gross structural 
changes in CK 1-expressing/3 cells. In early stages, the cells 
containing bundles of the ectopic CK did not display any 
other conspicuous alterations and their cytoplasm was still 
crowded with  the  typical dense-cored,  insulin-containing 
secretory vesicles (see Fig. 6, a-d).  However, in more ad- 
vanced stages, a number of/3 cells were seen that contained 
dense CK bundles in the cytoplasm (and often also in the 
nucleoplasm) but were drastically depleted in  dense-core 
vesicles (Figs.  8, a-d,  and 9, a-d). 
In the electron microscope, such/3 cells which appeared 
"light" due to lower frequency of dense-core vesicles, were 
best identified at low magnification, often in the immediate 
vicinity of normal-looking islet cells with numerous dense- 
core vesicles (Figs. 8, a  and b, and 9, a and b). In the same 
"light cells; we often found, on careful examination, cyto- 
plasmic CK bundles together with aggregates of CK filament 
material throughout the nucleus. These intranuclear CK ag- 
gregates did not show regular associations with blocks of 
dense chromation and/or the nucleolus (Fig. 9, b-d). 
Otherwise, most CK 1-positive/3 cells, whether depleted 
in dense-core vesicles or not, did not reveal major altera- 
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pancreatic islets of transgenic 
mice characterized by the ap- 
pearance of massive CK bun- 
dies and a reduction of dense- 
core variables. Islets of mice 
of line Tg-RIP-HI/10 with be- 
ginning IDDM contain a num- 
ber of/3 cells the cytoplasm of 
which,  at low magnification, 
appears "lighff in overall elec- 
tron density, due to the drastic 
reduction  in the  number and 
frequency of dense-core vesi- 
cles. These cells also contain 
extensive CK IF bundles typi- 
cal of  those containing epider- 
mal CK 1 and/or  10.  (a and 
b) Survey micrographs  show- 
ing  light  cells  with  very 
few dense-core  vesicles,  sur- 
rounded  by  normal-looking 
cells  rich  in dense-core  vesi- 
cles (denoted by roman numer- 
als);  another  light-appearing 
cell is designated II in b. On 
closer inspection,  these  light 
cells are seen to contain many 
bundles of  densely packed CK 
IFs (denoted by brackets  and 
arrows). (  c and d) Successively 
higher magnifications of a re- 
gion of (b), showing details of 
the distribution and organiza- 
tion of  these CKbundies which 
often are concentrated  in the 
juxtanuclear  region,  more or 
less parallel to the nuclear en- 
velope (arrows in c; individual 
filaments can be recognized in 
d).  N,  nuclei;  M,  mito- 
chondria.  Bars:  (a  and  b)  5 
#m; (c) 1/xm; (d) 0.5/zm. 
tions. Only rarely did we observe nuclear pyknosis, exten- 
sive (auto-)phagocytosis or other features characteristic of 
apoptotic or necrotic damage. 
Discussion 
Obviously, for the secretory activity and the viability of pan- 
creatic islet/~ cells the specific composition and/or arrange- 
ment of its IF system does matter. The drastic changes of the 
cytoskeleton and of insulin secretory vesicle frequency, to- 
gether with IDDM development, that we have observed in 
these cells upon ectopic expression of a certain kind of CK, 
i.e., CK 1, show that the correct IF cytoskeleton can be of 
critical importance for the function and stability of a given 
cell  type.  This observation contrasts  a  series of previous 
studies reporting that the advent of nonorthotypic IF proteins 
in various cultured cell lines, be it spontaneous, induced by 
drug treatment, or resulting from gene transfection, does not 
result in demonstrable changes of cell shape,  function,  or 
proliferation (e.g.,  6,  8,  34,  51,  57,  67,  73). 
The remarkable specificity of transgenic IDDM induction 
observed for CK 1, but not for CK 10, excludes several possi- 
ble simple explanations of regulation and pathogenesis. Ob- 
viously, the structural changes in, and losses of,/3 cells and 
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nuclear filament bundles of  hu- 
man  epidermal  cytokeratins 
ectopically expressed in trans- 
genie mice. "Light" pancreatic 
islet  /~  cells  (N,  nuclei)  of 
transgenic mice (same as de- 
scribed in Fig. 7) also contain 
densely  stained  intranuclear 
filament  bundles  or  deposits 
of tightly packed CK material 
(a and b, survey micrographs; 
c and d, partial magnifications 
of regions shown in b) that is 
not  seen  in  the  surrounding 
normal-looking  "dark"  cells 
rich  in  dense-core  vesicles 
(Roman numerals;  V in b de- 
notes  a  vascular  lumen  of a 
capillary). These intranuclear 
IF  protein  structures  are 
denoted by arrowheads, cyto- 
plasmic IF bundles by arrows, 
and  a  particularly  massive 
paracrystalline IF array (in d) 
by a double arrow. The pres- 
ence of some residual dense- 
core  vesicles  in  these  cells 
identifies  them as  endocrine 
cells  (see,  e.g.,  the  enrich- 
ment at the basal membrane of 
the "light cell" shown in b and 
the  vesicle  indicated  by  an 
asterisk at the right margin in 
d. NE, nuclear envelope; No, 
nucleolus;  M,  mitochondria. 
Bars:  (a  and  b)  2  #m;  (c) 
1 /~m; (d) 0.5/~m. 
the development of hyperglycemia are not merely the result 
of the occurrence of a foreign CK, a generally greater abun- 
dance of unusually massive IF bundles,  or the competition 
for RIP-binding transcription factors. At present, we cannot 
explain why the/3 cells tolerate the type I CK 10 but not the 
type II CK 1,  even when the latter is synthesized together 
with its "natural" partner, CK 10.  It is clear, however, that 
the  "toxic" and  diabetogenic  principle  is  associated  with 
CK 1. 
CK IFs are obligatory heteropolymers of type I and II CK 
polypeptides. As CK polypeptides of one type alone would 
not form IFs unless they can bind to a CK of complementary 
type (e.g., 38, 39, 48, 51, 53), it is evident that the epidermal 
CK 1 or CK 10 additionally synthesized in/3 cells must be 
stabilized by stoichiometric amounts of complementary type 
murine CK(s).  The results of our double-immunolabel ex- 
periments, showing colocalization of transgenic CK 1 or CK 
10 with endogenous CK 8 (in the case of Tg-RIP-H10) or CK 
18 (in Tg-RIP-H1 mice), suggest that here the synthesis of the 
specific complementary endogenous CK is upregulated,  to 
contribute to the formation of the new heterotypic and heter- 
ologous CK filaments. 
In our transgenic experiments, the synthesis in/3-islet cells 
of large amounts of CKs that normally are synthesized only 
during suprabasal differentiation of epidermal keratinocytes 
results  in  the  accumulation  of bundles  of IFs  packed  as 
tightly and stained as densely as the CK "macrofibrils" typi- 
cal  of the  upper  strata  of epidermis  and  other  stratified 
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cell layer of epidermis,  this dense IF  fasciation involves 
specific aggregation-promoting molecules such as filaggrin 
(17) or other IF-associating proteins (IFAPs; for reviews see 
17, 75).  However,  in the/3-islet cells containing IF bundles 
of transgenic CKs  1 and/or 10 we have not detected, im- 
munohistochemically, any filaggrin (data not shown). There- 
fore, although we cannot formally exclude the contribution 
of a/3 cell-specific IFAP, we take this as an indication that 
tight macrofibril-like IF bundling is a potential intrinsic to 
CKs 1 and/or 10 (for a high aggregation tendency, although 
unoriented, of IFs formed from purified CKs 1 and 10 see 
reference 24). An unusually high intrinsic stability and resis- 
tance to solubilization and denaturation for IFs containing 
CKs 1 and 10 has also been reported (see references 23, 27), 
suggesting that in the 13 cells the IFs containing transgenic 
CKs  1 and/or 10 have structural properties different from 
those of the sparse, loose and short IFs comprising only en- 
dogenous CKs 8 and 18. 
Completely unexpected was our observation that fibrillar 
structures containing the foreign CK 1 frequently appear not 
only in the cytoplasm but also in the nucleus. In some cells, 
it even looked as if  the majority, if  not the total, of  the ectopic 
CK was deposited within the confinements of the nuclear 
envelope. Recent observations of nuclear IF accumulations 
of several CKs with deleted carboxyterminal ("tail") domains 
(6) as well as tail-truncated vimentin (20) indicate that this 
part of the molecule normally contributes to its correct, i.e., 
cytoplasmic compartmentalization. Our present results now 
show that nuclear accumulation of CK IFs is not simply a 
consequence of tail truncation but can also be observed with 
certain intact CK molecules appearing in the '%vrong cell 
type" This points to the possible importance of IF-protein 
interaction with other cell-specific elements to restrict IF 
distribution and secure their correct compartmentalization 
to the cytoplasm. The mechanisms by which such relatively 
large molecules reach (and accumulate in) the interphase nu- 
cleus are unclear. Apparently, their nuclear uptake does not 
depend on a special nuclear "accumulation"  sequence (for re- 
view see reference 74). 
Whether the unusual accumulation of ectopic CK  1 in 
nuclei of/3 cells contributes to IDDM pathogenesis also re- 
mains to be examined. At any rate, our study provides a clear 
example to show that the synthesis of a "wrong" or of "too 
much" IF protein in a  cell can result in dysfunction and 
death, be it by its interference with cytoplasmic functions or 
due to its incorrect, i.e., nuclear location. In future trans- 
genic experiments we will study the specific mechanisms of 
nuclear IF deposition and functional consequences. 
Development of IDDM as a consequence of the transgenic 
introduction of ectopic proteins into/3 cells of pancreatic is- 
lets has not been noticed with a large number of gene con- 
structs (22, 37) but has been reported only for certain appar- 
ently  unrelated  genes,  including  those  encoding  Ha-ras 
protein (21, 22), calmodulin (26), -/-interferon (IFN-3,; 72), 
several viral antigens (65, 70), and class I or II histocompati- 
bility complex (MHC) polypeptides (5, 9, 37, 56, 58, 59, 72). 
In most of these studies, IDDM was associated with reduced 
insulin secretion and/or a loss of/3 cells. Obviously, the/3 
cell and its secretory function is sensitive to a diversity of 
disturbances  of cellular architecture and protein  compo- 
sition. 
However, while for some of these situations/3 cell patho- 
genesis was ascribed to autoimmune reaction and inllamma- 
tory destruction resulting in histological insulitis (e.g., 65, 
70, 72), such an immunological basis of cell dysfunction  dis- 
ease is considered unlikely in the other studies. Recently, au- 
toantibodies to peripherin, a minor IF protein of islet/3 cells, 
have been reported to be characteristic for the insulitits and 
IDDM of nonobese diabetic mice (10). In our study we have 
not noticed the occurrence of significant antibodies to/3-cell 
antigens or to other pancreatic structures in the sera of  trans- 
genie mice expressing the RIP-CK 1 gene, nor any signs of 
insulitis, including infiltration of lymphocytes and/or mac- 
rophages/mononucleocytes. This suggests that autoimmune 
reactions are not causally involved in IDDM development of 
mice expressing CK 1 in their/3 ceils. Consequently, this 
form of IDDM should not yet be regarded as typical "type 
I IDDM" (25) but rather as an IDDM form sui generis. In 
this respect, the CK 1-induced/3-cell dysfunction  and deple- 
tion seems to be similar to certain other transgenic IDDM 
models from which it, however, differs in several other char- 
acteristics: in the CK 1-induced IDDM we have not noted a 
preference of  pathogenesis for males as in MHC (59; see ref- 
erence 56) and Ha-ms (21, 22) transgenic animals. While ir- 
regular organization and some vesicle reduction ("degranula- 
tion") of/3 cells have also been described for mice expressing 
"foreign" MHC genes (e.g., 5, 56, 59, 72) or overexpressing 
calmodulin (26), the markedly decreased frequency of secre- 
tory vesicles described in this study has only been reported 
for the male-specific Ha-ms situation (22) in which the de- 
fect appeared late, i.e., after "~5 mos. 
At present, we cannot decide which pathogenic mecha- 
nism relates the advent of CK 1 and CK 1-containing fibrils 
to the disappearance of secretory vesicles and, finally, to cell 
death. As IFs can associate intimately with various membra- 
nous structures (14), a direct interaction with the membranes 
of the secretory apparatus is one possibility to consider but 
an interference with much earlier functions in the chains of 
syntheses, such as inhibitory effects in the cell nucleus by the 
intranuclear CK I-containing aggregates is likewise possi- 
ble.  Hopefully, future experiments,  using other CK gene 
constructs, including CK 1 deletion mutations and some that 
will result in overproduction of endogenous CK 8 or 18, will 
help to identify the specific pathogenic principles and do- 
mains in CK 1 and to understand why transgenlc changes in 
the cellular complement of certain proteins result in an im- 
pairment of/3-cell functions and survival,  whereas other 
transgenically introduced proteins are well tolerated. 
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